Debiopharm taps ViewsML AI-driven platform to streamline biomarker detection in oncology research. VANCOUVER, BRITISH COLUMBIA, CANADA, June 17, 2025 /EINPresswire.com/ -- ViewsML, a techbio company specializing in AI-driven virtual...

NEW YORK – Artificial intelligence company Nucleai and Jefferson Health on Tuesday announced a collaboration to discover histological biomarkers that predict response to immunotherapy. Tel Aviv-based Nucleai will use its ATOM platform to...